For Healthcare Providers
Resources for healthcare providers and prescribers on managing drug shortages, helping patients find medications, and savings programs.
2525 articles
Lentocilin Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on the Lentocilin and Bicillin L-A shortage in 2026: supply status, prescribing guidance, administration differences, and patient prioritization.
Levalbuterol Shortage: What Providers and Prescribers Need to Know in 2026
Providers prescribing Levalbuterol (Xopenex) need to understand the 2026 supply landscape. Here's what's happening and clinical strategies to help your patients.
Lomustine Shortage: What Providers and Prescribers Need to Know in 2026
Lomustine (Gleostine) access challenges affect patient care. This 2026 guide for oncology providers covers supply status, prescribing tips, alternatives, and financial resources.
Loryna 28 Day Shortage: What Providers and Prescribers Need to Know in 2026
Patients are struggling to fill Loryna 28 Day prescriptions in 2026. Here's what providers need to know about availability, substitution, and clinical guidance.
37,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.
Methotrexate Shortage: What Providers and Prescribers Need to Know in 2026
The methotrexate injection shortage persists in 2026. Here is what rheumatologists, oncologists, and PCPs need to know about availability and alternatives.
Mycophenolate Mofetil Shortage: What Providers and Prescribers Need to Know in 2026
The mycophenolate mofetil shortage creates real clinical challenges for transplant teams and rheumatologists. Here's what prescribers need to know and do in 2026.
Nextstellis 28 Day Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for OB/GYNs, PCPs, and NPs on Nextstellis availability challenges in 2026, including prescribing workarounds, alternatives, and patient communication strategies.
Nivestym Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for oncologists and prescribers on Nivestym (filgrastim-aafi) availability challenges in 2026, including biosimilar alternatives, formulary navigation, and patient support resources.
Norgestrel Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview for OB/GYNs, PCPs, and NPs: norgestrel (Opill) availability in 2026, patient access barriers, and prescribing alternatives when needed.
Nuedexta Shortage: What Providers and Prescribers Need to Know in 2026
While Nuedexta is not on the FDA shortage list, prescribers are seeing real access barriers. Here's what providers need to know about availability, PA, and patient support in 2026.
Spinraza (Nusinersen) Access Update: What Providers and Prescribers Need to Know in 2026
The FDA approved a high-dose Spinraza regimen in March 2026, new gene therapies have entered the market, and insurer policies are evolving. Here's what SMA prescribers need to know.
Ogsiveo Shortage: What Providers and Prescribers Need to Know in 2026
Ogsiveo is not in FDA shortage, but access issues, prior auth burdens, and the 2025 tablet change are causing real disruptions. Key facts for prescribers.